Category: Multiple Sclerosis (MS)
Global Multiple Sclerosis (MS)
-
Global Non-Oncology Biopharmaceuticals Market - 2025-2033
... 2025-2033. The global non-oncology biopharmaceuticals market is growing due to the rising demand for advanced biologic therapies for chronic and non-cancerous conditions. Technological advancements in biologics, such as monoclonal antibodies, recombinant proteins, and gene therapies, ... Read More
-
Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious, Neurological), Application (Diagnostic, Research) - Global Forecast to 2030
... to the advantage that these assay kits offer standardized and optimized protocols, facilitating accurate and efficient analysis of biomarkers in various biological samples, thus contributing significantly to diagnostic and research endeavors in healthcare. Further, advances ... Read More
-
2025 Global Forecast for Multiple Sclerosis Therapeutics Market (2026-2031 Outlook)-High Tech Outlook Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 ... Read More
-
Multiple Sclerosis Drugs Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
... report by Grand View Research, Inc. Increased funding for R&D of neurological biomarkers to boost development of new drugs is expected to impel market growth. National Institute of Neurological Disorders and Stroke provides funding opportunities ... Read More
-
Beta Interferon
... CAGR of 3.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$968.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is estimated at ... Read More
-
Multiple Sclerosis Drugs
... at a CAGR of 6.7% over the analysis period 2024-2030. Immmunomoderator Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$13.2 Billion by the end of ... Read More
-
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
... is projected to surge to a value of USD 134.27 billion in 2030 from USD 67.30 billion in 2024, growing at a CAGR of 12.2%. Favorable reimbursement policies in North America and Europe coupled with ... Read More
-
Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and Corticosteroids), By Application (Arthritis, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Inflammatory Bowel Disease (IBD), and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast ... Read More
-
Global Active Wheelchair Market Size, Share & Trends Analysis by Type (Manual Wheelchair, Powered Wheelchair), by Indication (Cerebral Palsy, Alzheimer’s Disease, Multiple Sclerosis), and Regional Forecasts 2022–2032
... witness significant growth, with the market size estimated at USD 1.58 billion in 2023 and projected to expand at a CAGR of 5.8% during the forecast period from 2024 to 2032. These mobility aids are ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Global Stem Cell Therapy for Multiple Sclerosis Market Growth (Status and Outlook) 2024-2030
... million in 2023. With growing demand in downstream market, the Stem Cell Therapy for Multiple Sclerosis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. ... Read More
-
Global Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Multiple Sclerosis Treatment is forecast to a readjusted size of US$ 19060 million by 2030 with a CAGR of 2.1% during review period. The research report highlights the growth potential ... Read More
-
Global Stem Cell Therapy for Multiple Sclerosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Multiple sclerosis is a nervous system disease, ... Read More
-
Global Targeted Drugs for Multiple Sclerosis Market Growth (Status and Outlook) 2024-2030
... it is expected to grow at a CAGR of %from 2024 to 2030. LPI (LP Information)' newest research report, the “Targeted Drugs for Multiple Sclerosis Industry Forecast” looks at past sales and reviews total world ... Read More
-
Stem Cell Therapy for Multiple Sclerosis Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... Sclerosis from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, ... Read More
-
Global Multiple Sclerosis Drugs Treatment Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Multiple Sclerosis Drugs Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Multiple Sclerosis Therapeutics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Multiple Sclerosis Therapeutics is forecast to a readjusted size of US$ 19240 million by 2030 with a CAGR of 2.1% during review period. The research report highlights the growth potential ... Read More
-
Global Secondary Progressive Multiple Sclerosis Drug Market Growth 2024-2030
... demand in downstream market, the Secondary Progressive Multiple Sclerosis Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Primary Progressive Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Primary Progressive Multiple Sclerosis Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Global Progressive Relapsing Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Progressive Relapsing Multiple Sclerosis Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032
... Research Organizations, and Others), and Region 2024-2032 The global neurological biomarkers market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.0 Billion by 2032, exhibiting a ... Read More
-
Multiple Sclerosis Therapies Market Report by Drug (Immunomodulators, Immunosuppressants), Drug Type (Biologic Drugs, Small Molecule Drugs), Route of Administration (Oral, Injectable, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
... multiple sclerosis therapies market size reached US$ 26.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.8 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. Multiple ... Read More
-
Global Multiple Sclerosis Treatment Market Report and Forecast 2024-2032
... grow at a CAGR of 4.10 % during the forecast period of 2024-2032, driven by advances in understanding individual genetic markers. The market is experiencing robust growth and is expected to reach USD 30.6 billion ... Read More
-
Global Specialty Pharmaceuticals Market 2024-2028
... report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More